Medicinal Chemistry Approaches for Combatting SARS-CoV-2 and COVID-19 Therapeutics
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The COVID-19 pandemic has underscored the need for innovative and adaptable solutions in medicinal chemistry to address the growing global health challenges. New strategies, including structure-based drug design, AI-driven drug discovery, and drug repurposing, have shown promising advancements in accelerating the creation of therapeutic treatments. Significant strides have been made in focusing on crucial viral proteins, particularly the main protease (Mpro) and RNA-dependent RNA polymerase (RdRp), which have created new opportunities for small-molecule inhibitors. Additionally, advancements in peptide-based therapies, monoclonal antibodies, and nanotechnology-enhanced drug delivery systems have expanded the tools available against SARS-CoV-2. However, significant challenges persist, such as addressing viral mutations, improving access to medications, and ensuring rapid scalability of treatments. Ongoing investment in interdisciplinary collaborations, enhanced screening technologies, and real-time genetic monitoring will be essential for refining these strategies. By adopting a proactive approach, medicinal chemistry can respond to the current pandemic and lay the groundwork for effectively tackling future viral threats with greater precision and efficiency.
Fields of Study & Subjects
SARS-CoV-2 and COVID-19 Research
Computational Drug Discovery Methods
COVID-19 Clinical Research Studies
Publication details
- Journal / source
- Fabad Journal of Pharmaceutical Sciences
- Volume
- 51
- Issue
- 1
- Pages
- 351–382
- Publication date
- 31 March 2026
- Language
- TR